Literature DB >> 9165536

Macromolecules as novel transdermal transport enhancers for skin electroporation.

R Vanbever1, M R Prausnitz, V Préat.   

Abstract

PURPOSE: Macromolecules were investigated as chemical enhancers of transdermal transport by skin electroporation. Although unable to enhance passive or iontophoretic transport, macromolecules are proposed to enhance electroporation-assisted delivery by stabilizing the increased permeability caused by high-voltage pulses.
METHODS: To test this hypothesis, we examined the timescale of transport, the influence of electrical protocol and the influence of macromolecule size, structure, and charge on enhancement of transdermal mannitol transport in vitro by heparin, dextran-sulfate, neutral dextran, and poly-lysine.
RESULTS: Skin electroporation increased transdermal mannitol delivery by approximately two orders of magnitude. The addition of macromolecules further increased transport up to five-fold, in support of the proposed hypothesis. Macromolecules present during pulsing enhanced mannitol transport after pulsing for hours, apparently by a macromolecule-skin interaction. No enhancement was observed during passive diffusion or low-voltage iontophoresis, suggesting that macromolecules interact specifically with transport pathways created at high voltage. Although all macromolecules studied enhanced transport, those with greater charge and size were more effective.
CONCLUSIONS: This study demonstrates that macromolecules can be used as transdermal transport enhancers uniquely suited to skin electroporation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9165536     DOI: 10.1023/a:1012161313701

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores.

Authors:  S I Sukharev; V A Klenchin; S M Serov; L V Chernomordik
Journal:  Biophys J       Date:  1992-11       Impact factor: 4.033

2.  Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors.

Authors:  R Vanbever; E LeBoulengé; V Préat
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

3.  Imaging regions of transport across human stratum corneum during high-voltage and low-voltage exposures.

Authors:  M R Prausnitz; J A Gimm; R H Guy; R Langer; J C Weaver; C Cullander
Journal:  J Pharm Sci       Date:  1996-12       Impact factor: 3.534

4.  Heparin alters transdermal transport associated with electroporation.

Authors:  J C Weaver; R Vanbever; T E Vaughan; M R Prausnitz
Journal:  Biochem Biophys Res Commun       Date:  1997-05-29       Impact factor: 3.575

5.  Transdermal transport of DNA antisense oligonucleotides by electroporation.

Authors:  T E Zewert; U F Pliquett; R Langer; J C Weaver
Journal:  Biochem Biophys Res Commun       Date:  1995-07-17       Impact factor: 3.575

6.  Transdermal delivery of metoprolol by electroporation.

Authors:  R Vanbever; N Lecouturier; V Préat
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

7.  Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro.

Authors:  D B Bommannan; J Tamada; L Leung; R O Potts
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

8.  Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy.

Authors:  R Heller; M J Jaroszeski; L F Glass; J L Messina; D P Rapaport; R C DeConti; N A Fenske; R A Gilbert; L M Mir; D S Reintgen
Journal:  Cancer       Date:  1996-03-01       Impact factor: 6.860

9.  Antitumor electrochemotherapy: new advances in the clinical protocol.

Authors:  C Domenge; S Orlowski; B Luboinski; T De Baere; G Schwaab; J Belehradek; L M Mir
Journal:  Cancer       Date:  1996-03-01       Impact factor: 6.860

10.  Transdermal delivery of heparin by skin electroporation.

Authors:  M R Prausnitz; E R Edelman; J A Gimm; R Langer; J C Weaver
Journal:  Biotechnology (N Y)       Date:  1995-11
View more
  8 in total

Review 1.  Synergistic effect of enhancers for transdermal drug delivery.

Authors:  S Mitragotri
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

2.  Combined effect of low-frequency ultrasound and iontophoresis: applications for transdermal heparin delivery.

Authors:  L Le; J Kost; S Mitragotri
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

3.  Transdermal delivery of macromolecules using skin electroporation.

Authors:  C Lombry; N Dujardin; V Préat
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

4.  Transdermal delivery of heparin using pulsed current iontophoresis.

Authors:  Stefania Pacini; Tiziana Punzi; Massimo Gulisano; Fabiola Cecchi; Simonetta Vannucchi; Marco Ruggiero
Journal:  Pharm Res       Date:  2006-12-21       Impact factor: 4.200

Review 5.  The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins.

Authors:  Nusrat A Motlekar; Bi-Botti C Youan
Journal:  J Control Release       Date:  2006-06-14       Impact factor: 9.776

6.  Saturated anionic phospholipids enhance transdermal transport by electroporation.

Authors:  Arindam Sen; Ya-Li Zhao; Sek Wen Hui
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

7.  Noninvasive routes of proteins and peptides drug delivery.

Authors:  P K Sharma; Sumedha Bansal; Arunabha Banik
Journal:  Indian J Pharm Sci       Date:  2011-07       Impact factor: 0.975

8.  Sodium alginate microneedle arrays mediate the transdermal delivery of bovine serum albumin.

Authors:  Yusuf K Demir; Zafer Akan; Oya Kerimoglu
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.